These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33305149)

  • 1. Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.
    Wongjarupong N; Yonli AT; Nagalo BM; Djigma FW; Somda SK; Hassan MA; Mohamed EA; Sorgho AP; Compaore TR; Soubeiga ST; Kiendrebeogo I; Sanou M; Diarra B; Yang HI; Chen CJ; Ouattara AK; Zohoncon TM; Martinson JJ; Buetow K; Chamcheu JC; Antwi SO; Borad MJ; Simpore J; Roberts LR
    Hepatol Commun; 2020 Dec; 4(12):1781-1792. PubMed ID: 33305149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
    Chun HS; Papatheodoridis GV; Lee M; Lee HA; Kim YH; Kim SH; Oh YS; Park SJ; Kim J; Lee HA; Kim HY; Kim TH; Yoon EL; Jun DW; Ahn SH; Sypsa V; Yurdaydin C; Lampertico P; Calleja JL; Janssen H; Dalekos GN; Goulis J; Berg T; Buti M; Kim SU; Kim YJ
    J Hepatol; 2024 Jan; 80(1):20-30. PubMed ID: 37734683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Han S; Lim YS
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35358094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA.
    Wang J; Zhu L; Zhang S; Zhang Z; Fan T; Cao F; Xiong Y; Pan Y; Li Y; Jiang C; Yin S; Tong X; Xiong Y; Xia J; Yan X; Liu Y; Liu X; Chen Y; Li J; Zhu C; Wu C; Huang R
    Emerg Microbes Infect; 2024 Dec; 13(1):2339944. PubMed ID: 38584592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
    Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
    BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Baseline Hepatitis B Virus DNA and On-Treatment Risk of Cirrhosis and Hepatocellular Carcinoma.
    Yang Z; Cheung RC; Jou JH; Lim JK; Lim YS; Wong RJ
    Gastroenterology Res; 2024 Jun; 17(3):109-115. PubMed ID: 38993547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.
    Zeng Y; Zhu C; Huang E; Xun Z; Zhang Y; Chen T; Lin C; Fu Y; Wu S; Yang B; Ou Q; Liu C
    Clin Chim Acta; 2024 Jan; 553():117739. PubMed ID: 38145642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Viral Load and On-treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort Study.
    Choi WM; Yip TC; Wong GL; Kim WR; Yee LJ; Brooks-Rooney C; Curteis T; Clark LJ; Jafry Z; Chen CH; Chen CY; Huang YH; Jin YJ; Jun DW; Kim JW; Park NH; Peng CY; Shin HP; Shin JW; Yang YH; Lim YS
    Clin Gastroenterol Hepatol; 2024 Aug; ():. PubMed ID: 39181430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
    Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
    Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum vitamin D and vitamin-D-binding protein levels in children with chronic hepatitis B.
    Huang CZ; Zhang J; Zhang L; Yu CH; Mo Y; Mo LY
    World J Gastroenterol; 2021 Jan; 27(3):255-266. PubMed ID: 33519140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.